Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue
Kevin Litchfield(The Francis Crick Institute), Ron Sinclair, Alexandre Harlé(Centre National de la Recherche Scientifique), Sergio A. Quezada(Wellcome Sanger Institute), Désirée Schnidrig(The Francis Crick Institute), Katey S.S. Enfield(The Francis Crick Institute), Siow Ming Lee(London Cancer), Lisa Pickering(Royal Marsden Hospital), Carol Jones(Roche (United States)), Mary Falzon, Iver Nordentoft(Aarhus University), Robert E. Hynds(University College London), Lisa L. Gallegos(Roche (United States)), Daniel L. Burgess, Lars Dyrskjøt(Aarhus University Hospital), Dionysis Papadatos-Pastos, Katherine F. Leith(Roche (United States)), Nicholas McGranahan(London Cancer), Tariq Enver(London Cancer), Sam M. Janes(CRUK Lung Cancer Centre of Excellence), Lewis Au(Royal Marsden NHS Foundation Trust), Samantha M. Hill(University of Arizona), Ariana Huebner(The Francis Crick Institute), Heidi Rosenbaum, Martin Förster, Nicolai J. Birkbak(Brigham and Women's Hospital), Daniel Hochhauser(Cancer Research UK), Aoune Barhoumi(Boston Children's Hospital), Zayd Tippu(Royal Marsden Hospital), Ian Proctor, Hang Xu(First Affiliated Hospital of Shihezi University Medical College), Stacey Stanislaw(Roche (United States)), Stephan Beck, Mariam Jamal-Hanjani(Cancer Research UK), Emilia Lim(The Francis Crick Institute), Lavinia Spain(The Francis Crick Institute), Kai‐Keen Shiu(The Francis Crick Institute), Thomas B.K. Watkins(The Francis Crick Institute), Peter Van Loo, Lisa Thompson(Royal Marsden Hospital), Philippe Lamy(Aarhus University Hospital), Stephen Hazell(Royal Marsden NHS Foundation Trust), Tanya Ahmad(University College London), Henning Walczak, Andrew Rowan(The Francis Crick Institute), John Bridgewater(Roche (United States)), Chris Abbosh(AstraZeneca (United Kingdom)), Stuart Horswell(The Francis Crick Institute), Jennifer Thomas(Royal Marsden Hospital), Peter J. Parker(MRC Protein Phosphorylation and Ubiquitylation Unit)
Cited by 77
Related Papers
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study
|The Lancet|2018|1.7k
The extended protein kinase C superfamily
|Biochemical Journal|1998|1.5k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k